| Title | Date | PubMed ID |
|---|
| Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma. | 2017 Feb 21 | 28099905 |
| The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O<sub>2</sub> activation. | 2017 Jan | 27815979 |
| Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases. | 2016 Sep 23 | 27502280 |
| HIF hydroxylase pathways in cardiovascular physiology and medicine. | 2015 Jun 19 | 26089364 |
| Hypoxia-inducible factor (HIF) network: insights from mathematical models. | 2013 Jun 10 | 23758895 |
| A dynamic model of the hypoxia-inducible factor 1α (HIF-1α) network. | 2013 Mar 15 | 23390316 |
| Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH). | 2012 Aug | 22687491 |
| The asparaginyl hydroxylase factor-inhibiting HIF is essential for tumor growth through suppression of the p53-p21 axis. | 2012 Jun 14 | 22002313 |
| The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. | 2012 Mar 1 | 22310300 |
| Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides. | 2011 Jul 15 | 21665470 |